Potential Benefits and Value of Biosimilars

Biosimilars have the potential to have a positive impact on patients and the healthcare system. They can reduce costs by offering a lower-cost treatment option and provide more treatment options for patients.

How Biosimilars Save on Costs

Biosimilars introduce competition into the healthcare system. As the number of treatment choices increases for a particular disease or condition, manufacturers are incentivized to reduce the prices of their products to maintain or increase market share.

How Biosimilars Affect the Marketplace(1-4)


The competition fostered by a marketplace with biosimilars could benefit every stakeholder in the healthcare system


Opportunity for system-wide cost savings


Headroom for greater investment in innovator products


More treatment options for patients with serious illnesses


Manufacturers incentivized to reduce prices

With rising healthcare costs, biosimilars contribute to a more sustainable healthcare system by providing patients with more treatment options.5


  1. Dolinar RO. Biosimilars are not generics. Endocrine Today. www.healio.com/endocrinology/practice-management/news/print/endocrinetoday/%7Bfd6accbd-a927-467b-ba5e-4f8796327816%7D/biosimilars-are-not-generics. Accessed August 1, 2022.
  2. Federal Trade Commission. Emerging health care issues: follow-on biologic drug competition. www.ftc.gov/os/2009/06/P083901biologicsreport.pdf. Accessed August 1, 2022.
  3. US Food and Drug Administration. Biosimilars action plan: balancing innovation and competition. July 2018.
  4. The Biosimilars Council. Biosimilars in the United States. http://biosimilarscouncil.org/wp-content/uploads/2019/03/Biosimilars-Council-Patient-Access-Study.pdf. Accessed August 1, 2022.
  5. US Food and Drug Administration. Biosimilar and Interchangeable Biologics. More Treatment Choices. 2021.